Medrio

medrio.com · San Francisco, United States of America

Medrio provides cloud-based electronic data capture (EDC) and eClinical software used to design, run, and manage clinical trials for biopharma, medical device, and contract research organizations, with a focus on decentralized and hybrid studies. Its platform supports study build, data collection, eConsent, and patient engagement, and it generates revenue through subscription licensing and related professional services.

  • Clinical Trial & Research Software
Revenue
$55.0M
Employees
350
Founded
2005
Headquarters
San Francisco, United States of America

What 27 Arbolus experts think of Medrio

NPS responses range from 4 to 10, with a mean NPS in the mid-7s and a notable cluster of highly positive (9–10) responses among high-spend, long-tenured users. Renewal intent is strong in accounts with more than 1 year of implementation and significant spend, while pilot-phase and smaller users show greater uncertainty. Sentiment drivers include ease of use, regulatory compliance, and customer support, with negative feedback focused on reporting flexibility and pilot user satisfaction. Overall Customer Sentiment: Positive

Who reviewed Medrio

Total customers 27 22 current · 5 former
Reviews growth +13 in six months
Seniority of respondents
  • C-Suite 52% (14)
  • Director 37% (10)
  • Manager 11% (3)
Operations Leader Manager NPS 10 Will renew
Data Leader Manager NPS 10 Will renew
Data Leader Director NPS 9

Employer names and spend open in the full report, along with the other 24 customers.

Everything 27 customers told us about Medrio.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

11 Net Promoter Score, from 27 scored reviews
  • Promoters 9
  • Passives 12
  • Detractors 6

Cumulative NPS by month

+0 over 6 months
  • Feb 8
  • Apr 7
  • May 8
  • Jun 8
  • Aug 8
  • Sep 8

Net Promoter Score across 4 reviews, accumulated up to each month. Category median 26 across 4 companies.

Praised

  • Improved Reporting
  • Enterprise Upsell from Pilots
  • AI-Driven Optimization
  • Customer Support

Criticised

  • Pilot User Preference for Alternatives
  • Limited Reporting Flexibility
  • Non-Critical for Advanced Trials
  • Reliance on Rave EDC

What customers say

Customer Support
“One of Medrio’s main advantages for us has been customer support and the ease of developing studies compared to other tools.”
User-Friendliness
“Medrio is designed to let studies be built and modified relatively quickly and easily, without needing intense programming or technical skills.”
Purpose-Built Compliance
“Medrio offers a more complete infrastructure for clinical trials than RedCap, with strong compliance features like audit trails, data validation, and electronic signatures.”

Renewal intent

Plan to renew 68%
  • Will renew 13
  • Undecided 5
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 75% 12 answers
  • Director 40% 5 answers
  • Manager 100% 2 answers
  • 8.8/10 Average score from customers who will renew
  • 6.4/10 Average score from undecided customers
  • 7/10 Average score from customers not renewing

Top alternatives

Most weighed by Medrio customers

Report

For people who use Medrio

Do you use Medrio at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 27 customers of Medrio have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.